Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. | Front Immunol | 2022 | 36189271 | PubTator, text mining | PubMed |
| Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer. | World J Gastrointest Oncol | 2022 | 36187390 | PubTator, text mining | PubMed |
| A Soluble NK-CAR Mediates the Specific Cytotoxicity of NK Cells toward the Target CD20+ Lymphoma Cells. | Aging Dis | 2022 | 36186137 | PubTator, text mining | PubMed |
| Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma. | Front Oncol | 2022 | 36185276 | PubTator, text mining | PubMed |
| CD1d-independent NK1.1+ Treg cells are IL2-inducible Foxp3+ T cells co-expressing immunosuppressive and cytotoxic molecules. | Front Immunol | 2022 | 36177042 | PubTator, text mining | PubMed |
| Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement. | Cell Rep | 2022 | 36170817 | PubTator, text mining | PubMed |
| AntiVIRmiR: A repository of host antiviral miRNAs and their expression along with experimentally validated viral miRNAs and their targets. | Front Genet | 2022 | 36159991 | PubTator, text mining | PubMed |
| MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. | Front Genet | 2022 | 36159990 | PubTator, text mining | PubMed |
| Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting. | Exp Hematol Oncol | 2022 | 36153595 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma. | Comput Math Methods Med | 2022 | 36148016 | PubTator, text mining | PubMed |
| Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST. | Int J Mol Sci | 2022 | 36142281 | PubTator, text mining | PubMed |
| Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood. | Cancers (Basel) | 2022 | 36139665 | PubTator, text mining | PubMed |
| Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise? | Cancers (Basel) | 2022 | 36139598 | PubTator, text mining | PubMed |
| Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes. | Nat Cancer | 2022 | 36138189 | PubTator, text mining | PubMed |
| Polycomb Directed Cell Fate Decisions in Development and Cancer. | Epigenomes | 2022 | 36135315 | PubTator, text mining | PubMed |
| miRNA in Molecular Diagnostics. | Bioengineering (Basel) | 2022 | 36135005 | PubTator, text mining | PubMed |
| Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond. | Front Immunol | 2022 | 36131910 | PubTator, text mining | PubMed |
| New insights on the role of human leukocyte antigen complex in primary biliary cholangitis. | Front Immunol | 2022 | 36119102 | PubTator, text mining | PubMed |
| Identifying celiac disease-related chemicals by transcriptome-wide association study and chemical-gene interaction analyses. | Front Genet | 2022 | 36118884 | PubTator, text mining | PubMed |
| Immunobiology of the biliary tract system. | J Hepatol | 2022 | 36116989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=32